Research and Development

New treatments for depression are few and far between; pharmaceutical companies have shied away from trying to develop new therapeutics …

MSD has revealed new efficacy data for Keytruda (permbrolizumab) as an adjuvant therapy in the treatment of resected, high-risk stage …

We’re excited to share with you our recently redesigned homepage, at the same site address: DIAglobal.org. The main objectives of …

PrimeVigilance will be exhibiting and celebrating its 10th anniversary at #DIAEurope2018, raffling 10 bottles of champagne away! Stop by their …

It’s Friday the 13th, but that doesn’t change a strong showing from the industry this week as it continued to …

South Korea’s Hanmi Pharmaceutical has announced its intention to terminate development of its lung cancer drug Olita (olmutinib) as it …

A massive effort funded by Cancer Research UK has been able to track the different evolutionary pathways of kidney cancer …

Eisai has teamed up with the Broad Institute, the Mycobacteria Research Laboratories at Colorado State University and the University of …

Roche’s Tecentriq had begun to show signs of reviving its hopes in the competitive PD-1/L1 market, succeeding in two Phase …

Come join Wickham Laboratories and Patient Guard for this free webinar on May 23rd to discuss Regulatory Changes in Medical …

Ipsen is set to expand its executive leadership team with the announcement of two new recruitments: Dr Ivana Magovčević-Liebisch will …

A partnership of the not-for-profit organisation Drugs for Neglected Diseases initiative (DNDi) and Egyptian drug firm Pharco Pharmaceuticals is working …

Pharmafile.com sat down with Kris Sterkens, Company Group Chairman of Janssen’s EMEA operations to discuss nearly three decades at the …

One of the major stumbling blocks that science has come up against, when trying to develop potential treatments for Alzheimer’s …

Verona Pharma has revealed that it is to part ways with its Chief Medical Officer at the end of the …